Literature DB >> 35781971

Dynamic inverse SNR-decorrelation OCT angiography with GPU acceleration.

Xiaofeng Deng1,2, Kaiyuan Liu1,2, Tiepei Zhu3, Dayou Guo1, Xiaoting Yin1, Lin Yao1, Zhihua Ding1, Juan Ye3, Peng Li1,4,5.   

Abstract

Dynamic OCT angiography (OCTA) is an attractive approach for monitoring stimulus-evoked hemodynamics; however, a 4D (3D space and time) dataset requires a long acquisition time and has a large data size, thereby posing a great challenge to data processing. This study proposed a GPU-based real-time data processing pipeline for dynamic inverse SNR-decorrelation OCTA (ID-OCTA), offering a measured line-process rate of 133 kHz for displaying OCT and OCTA cross-sections in real time. Real-time processing enabled automatic optimization of angiogram quality, which improved the vessel SNR, contrast-to-noise ratio, and connectivity by 14.37, 14.08, and 9.76%, respectively. Furthermore, motion-contrast 4D angiographic imaging of stimulus-evoked hemodynamics was achieved within a single trail in the mouse retina. Consequently, a flicker light stimulus evoked an apparent dilation of the retinal arterioles and venules and an elevation of the decorrelation value in the retinal plexuses. Therefore, GPU ID-OCTA enables real-time and high-quality angiographic imaging and is particularly suitable for hemodynamic studies.
© 2022 Optica Publishing Group under the terms of the Optica Open Access Publishing Agreement.

Entities:  

Year:  2022        PMID: 35781971      PMCID: PMC9208597          DOI: 10.1364/BOE.459632

Source DB:  PubMed          Journal:  Biomed Opt Express        ISSN: 2156-7085            Impact factor:   3.562


  42 in total

Review 1.  The clinical implications of recent studies on the structure and function of the retinal microvasculature in diabetes.

Authors:  Carol Yimlui Cheung; M Kamran Ikram; Ronald Klein; Tien Yin Wong
Journal:  Diabetologia       Date:  2015-02-11       Impact factor: 10.122

2.  Blood flow velocity quantification using split-spectrum amplitude-decorrelation angiography with optical coherence tomography.

Authors:  Jason Tokayer; Yali Jia; Al-Hafeez Dhalla; David Huang
Journal:  Biomed Opt Express       Date:  2013-09-03       Impact factor: 3.732

3.  Graphics processing unit accelerated optical coherence tomography processing at megahertz axial scan rate and high resolution video rate volumetric rendering.

Authors:  Yifan Jian; Kevin Wong; Marinko V Sarunic
Journal:  J Biomed Opt       Date:  2013-02       Impact factor: 3.170

4.  Regulation of blood flow in the retinal trilaminar vascular network.

Authors:  Tess E Kornfield; Eric A Newman
Journal:  J Neurosci       Date:  2014-08-20       Impact factor: 6.167

5.  Calibration of optical coherence tomography angiography with a microfluidic chip.

Authors:  Johnny P Su; Rahul Chandwani; Simon S Gao; Alex D Pechauer; Miao Zhang; Jie Wang; Yali Jia; David Huang; Gangjun Liu
Journal:  J Biomed Opt       Date:  2016-08-01       Impact factor: 3.170

6.  Complex-based OCT angiography algorithm recovers microvascular information better than amplitude- or phase-based algorithms in phase-stable systems.

Authors:  Jingjiang Xu; Shaozhen Song; Yuandong Li; Ruikang K Wang
Journal:  Phys Med Biol       Date:  2017-12-19       Impact factor: 3.609

7.  Real-time cross-sectional and en face OCT angiography guiding high-quality scan acquisition.

Authors:  Xiang Wei; Acner Camino; Shaohua Pi; Tristan T Hormel; William Cepurna; David Huang; John C Morrison; Yali Jia
Journal:  Opt Lett       Date:  2019-03-15       Impact factor: 3.776

8.  Hematocrit dependence of flow signal in optical coherence tomography angiography.

Authors:  Jianlong Yang; Johnny Su; Jie Wang; Silu Men; Yali Jia; David Huang; Gangjun Liu
Journal:  Biomed Opt Express       Date:  2017-01-11       Impact factor: 3.732

9.  In vivo imaging of the microcirculation of the volar forearm using correlation mapping optical coherence tomography (cmOCT).

Authors:  Joey Enfield; Enock Jonathan; Martin Leahy
Journal:  Biomed Opt Express       Date:  2011-04-13       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.